These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Influence of etiology on host immunity in liver cirrhosis patients with advanced hepatocellular carcinoma receiving intra-arterial chemotherapy. Nagai H; Mukozu T; Kanekawa T; Matsui T; Kanayama M; Wakui N; Momiyama K; Ishii K; Igarashi Y; Sumino Y Hepatogastroenterology; 2013 Jun; 60(124):858-63. PubMed ID: 23732780 [TBL] [Abstract][Full Text] [Related]
4. Influence of the etiology of liver cirrhosis on the response to combined intra-arterial chemotherapy in patients with advanced hepatocellular carcinoma. Kanayama M; Nagai H; Sumino Y Cancer Chemother Pharmacol; 2009 Jun; 64(1):109-14. PubMed ID: 18979100 [TBL] [Abstract][Full Text] [Related]
5. Hepatotoxicity of intra-arterial combination chemotherapy in patients with liver cirrhosis and advanced hepatocellular carcinoma. Nagai H; Matsui T; Kanayama M; Momiyama K; Shizawa K; Wakui N; Shinohara M; Watanabe M; Iida K; Ishii K; Igarashi Y; Sumino Y Cancer Chemother Pharmacol; 2010 Nov; 66(6):1123-9. PubMed ID: 20180123 [TBL] [Abstract][Full Text] [Related]
7. Comparison of hepatic arterial infusion chemotherapy versus sorafenib monotherapy in patients with advanced hepatocellular carcinoma. Kawaoka T; Aikata H; Hyogo H; Morio R; Morio K; Hatooka M; Fukuhara T; Kobayashi T; Naeshiro N; Miyaki D; Hiramatsu A; Imamura M; Kawakami Y; Takahashi S; Waki K; Tsuji K; Kohno H; Kohno H; Moriya T; Chayama K J Dig Dis; 2015 Sep; 16(9):505-12. PubMed ID: 26121102 [TBL] [Abstract][Full Text] [Related]
8. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases. Ando E; Tanaka M; Yamashita F; Kuromatsu R; Yutani S; Fukumori K; Sumie S; Yano Y; Okuda K; Sata M Cancer; 2002 Aug; 95(3):588-95. PubMed ID: 12209752 [TBL] [Abstract][Full Text] [Related]
9. A randomized study of cisplatin and 5-FU hepatic arterial infusion chemotherapy with or without adriamycin for advanced hepatocellular carcinoma. Song MJ; Bae SH; Chun HJ; Choi JY; Yoon SK; Park JY; Han KH; Kim YS; Yim HJ; Um SH; Chung WJ; Hwang JS; Cho SB; Eun JR Cancer Chemother Pharmacol; 2015 Apr; 75(4):739-46. PubMed ID: 25663125 [TBL] [Abstract][Full Text] [Related]
11. Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis. Hayaishi S; Chung H; Kudo M; Ishikawa E; Takita M; Ueda T; Kitai S; Inoue T; Yada N; Hagiwara S; Minami Y; Ueshima K Dig Dis; 2011; 29(3):326-32. PubMed ID: 21829025 [TBL] [Abstract][Full Text] [Related]
12. Changes of host immunity in relation to efficacy in liver cirrhosis patients with advanced hepatocellular carcinoma treated by intra-arterial chemotherapy. Momiyama K; Nagai H; Sumino Y Cancer Chemother Pharmacol; 2009 Jul; 64(2):271-7. PubMed ID: 19011857 [TBL] [Abstract][Full Text] [Related]
13. Clinical outcome of sorafenib treatment in patients with advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy. Miyaki D; Aikata H; Kan H; Fujino H; Urabe A; Masaki K; Fukuhara T; Kobayashi T; Naeshiro N; Nakahara T; Kawaoka T; Hiramatsu A; Takahashi S; Ishikawa M; Kakizawa H; Awai K; Chayama K J Gastroenterol Hepatol; 2013 Dec; 28(12):1834-41. PubMed ID: 23808713 [TBL] [Abstract][Full Text] [Related]
14. Hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil and cisplatin with or without interferon-alpha for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis. Eun JR; Lee HJ; Moon HJ; Kim TN; Kim JW; Chang JC Scand J Gastroenterol; 2009; 44(12):1477-86. PubMed ID: 19958061 [TBL] [Abstract][Full Text] [Related]
15. Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinoma. Park JY; Ahn SH; Yoon YJ; Kim JK; Lee HW; Lee DY; Chon CY; Moon YM; Han KH Cancer; 2007 Jul; 110(1):129-37. PubMed ID: 17508408 [TBL] [Abstract][Full Text] [Related]
16. Role and limitation of neoadjuvant hepatic arterial infusion chemotherapy in advanced hepatocelluar carcinoma patients with Child-Pugh class A. Lee BH; Lee DS; Cho CW; Yun SS World J Surg Oncol; 2019 Aug; 17(1):143. PubMed ID: 31416447 [TBL] [Abstract][Full Text] [Related]
18. [Effect of low dose 5-fluorouracil and cisplatin intra-arterial infusion chemotherapy in advanced hepatocellular carcinoma with decompensated cirrhosis]. Lim TY; Cheong JY; Cho SW; Sim SJ; Kim JS; Choi SJ; Choi JW; Kwon HC; Lee KM; Kim JK; Won JH; Yoo BM; Lee KJ; Hahm KB; Kim JH Korean J Hepatol; 2006 Mar; 12(1):65-73. PubMed ID: 16565607 [TBL] [Abstract][Full Text] [Related]
19. A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma. Takeshita S; Ichikawa T; Nakao K; Miyaaki H; Shibata H; Matsuzaki T; Muraoka T; Honda T; Otani M; Akiyama M; Miuma S; Ozawa E; Fujimito M; Eguchi K Nutr Res; 2009 Feb; 29(2):89-93. PubMed ID: 19285598 [TBL] [Abstract][Full Text] [Related]